New Challenging Systemic Therapies for Juvenile Scleroderma: A Comprehensive Review
<b>Background:</b> Juvenile scleroderma (JS) comprises a group of rare chronic autoimmune and fibrosing disorders in children, primarily presenting as juvenile localized scleroderma (jLS) or juvenile systemic sclerosis (jSS). While jLS predominantly affects the skin and subcutaneous tiss...
Saved in:
| Main Authors: | Chiara Sassetti, Claudia Borrelli, Martha Mazuy, Cristina Guerriero, Donato Rigante, Susanna Esposito |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/5/643 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EXPERIENCE OF RITUXIMAB TREATMENT IN A PATIENT WITH JUVENILE SCLERODERMA
by: E. I. Alexeeva, et al.
Published: (2012-05-01) -
Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature review
by: Natalia Vasquez-Canizares, et al.
Published: (2025-05-01) -
Fibrosing arthropathy in juvenile scleroderma
by: D. A. Dibrov, et al.
Published: (2021-04-01) -
Clinical and Epidemiological Characteristics of Scleroderma in Children of the Samara Region: a Single-Stage Retrospective Study
by: Juliya S. Bogomolova, et al.
Published: (2025-05-01) -
Juvenile localized scleroderma: a large retrospective cohort study from a tertiary care center
by: Bugra Han Egeli, et al.
Published: (2025-06-01)